File(s) not publicly available
Differences in signalling and phenotypic effects in melanoma between receptor tyrosine kinases that confer resistance to BRAF inhibitors
Version 2 2024-06-04, 14:53Version 2 2024-06-04, 14:53
Version 1 2023-04-27, 04:40Version 1 2023-04-27, 04:40
conference contribution
posted on 2024-06-04, 14:53 authored by Frederic Zhentao Li, Rachel Ramsdale, Amardeep DhillonAmardeep Dhillon, Grant McArthur, Petranel FerraoDifferences in signalling and phenotypic effects in melanoma between receptor tyrosine kinases that confer resistance to BRAF inhibitors
History
Volume
14Pagination
C70-C70Location
Boston, MAPublisher DOI
Start date
2015-11-05End date
2015-11-09Language
engPublication classification
E3.1 Extract of paperTitle of proceedings
AACR-NCI-EORTC 2015 : Molecular Targets and Cancer Therapeutics : Proceedings of the American Association for Cancer Research 2015 conferenceEvent
American Association for Cancer Research. Conference (2015 : Boston, MA)Issue
12_ Supplement_2Publisher
American Association for Cancer ResearchPlace of publication
Philadelphia, PASeries
Molecular Cancer TherapeuticsUsage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC